Skip to main content
Clinical Trials/NCT06573489
NCT06573489
Recruiting
Phase 4

Minimum Effective Dose and Maintenance Effectiveness of Fospropofol for General Anesthesia Induction in Adult Laparoscopic Abdominal Surgery: A Randomized, Single-Blind, Clinical Study

Hui Xu1 site in 1 country373 target enrollmentSeptember 15, 2024

Overview

Phase
Phase 4
Intervention
Fospropofol
Conditions
Drug Safety
Sponsor
Hui Xu
Enrollment
373
Locations
1
Primary Endpoint
Incidence of injection pain
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This protocol is a clinical study of fospropofol disodium for general anesthesia in adults undergoing laparoscope-assisted abdominal surgery. The study has three main objectives: First, to explore the use of propofol disodium as the lowest effective dose for induction of general anesthesia; Secondly, to evaluate the efficacy and safety of fospropofol disodium in the maintenance phase of general anesthesia, and to determine its effective dose range; Finally, the effects of fospropofol disodium on Bispectral Index during induction, maintenance and recovery were studied, and compared with propofol to understand its characteristic changes. The randomized, single-blind, controlled design of the study, with an expected enrollment of 373 patients, was designed to achieve its objectives through a three-phase trial design to provide important clinical information about the safety and efficacy of the use of propofol disodium.

Detailed Description

1. To explore the lowest effective dose of fospropofol disodium for general anesthesia induction in adult laparoscopic abdominal surgery 2. Observation on efficacy, safety and effective dose range of propofol disodium for general anesthesia maintenance in adult laparoscopic abdominal surgery 3. To study the changes of Bispectral Index in the brain of patients treated with propofol during induction, maintenance and recovery of general anesthesia during laparoscopic abdominal surgery in adults, and to compare with BIS(Bispectral Index) monitoring under propofol, and to study the characteristic changes of BIS(Bispectral Index) waveform in patients treated with propofol disodium.

Registry
clinicaltrials.gov
Start Date
September 15, 2024
End Date
July 1, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Hui Xu
Responsible Party
Sponsor Investigator
Principal Investigator

Hui Xu

Professor

Tongji Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult age (18-65 years old)
  • ASA(American Society of Anesthesiologists)grade I\~II
  • The estimated operation time is more than 3h, and laparoscopic abdominal surgery under general anesthesia is planned
  • BMI value 18-30kg /m2
  • Voluntary signing of informed consent

Exclusion Criteria

  • Those who have contraindications to general anesthesia or have a history of anesthesia accidents;
  • Patients with craniocerebral loss, intracranial hypertension, stroke, unstable angina pectoris, myocardial infarction;
  • Respiratory insufficiency, obstructive pulmonary disease, presence of a difficult airway, or determination of tracheal intubation difficulty (modified Markov score level III or IV)
  • uncontrolled diabetes or high blood pressure;
  • A history of drug use, alcoholism or drug dependence;
  • Abuse or long-term use of narcotic, sedative and analgesic drugs;
  • Those who are known or suspected to be allergic to or contraindicated by the process administration of various components or protocols of the study drug (sufentanil citrate injection, propofol medium/long chain fat milk, remifentanil hydrochloride for injection, and propofol disodium for injection);
  • People with a history of mental illness;
  • Participants in any drug clinical trial within 1 month before screening;
  • Pregnant and lactating women; The reluctance of fertile women or men to use contraception throughout the trial; Subjects (including male subjects) who plan to become pregnant within 3 months after the trial;

Arms & Interventions

Fospropofol group

patients in the fospropofol group received propofol phosphate, sufentanil, and rocuronium.

Intervention: Fospropofol

Propofol group

patients in the propofol group received propofol, sufentanil, and rocuronium.

Intervention: Propofol

Outcomes

Primary Outcomes

Incidence of injection pain

Time Frame: During induction of anesthesia

Incidence of perceived injection pain during anesthesia induction

Incidence of perioperative hypotension

Time Frame: From the beginning to the end of surgery

Incidence of hypotension throughout perioperative period

Secondary Outcomes

  • Glomerular filtration rate(First day after surgery)
  • Urea nitrogen(First day after surgery)
  • Creatinine(First day after surgery)
  • Eeg dual frequency exponential waveform(From the beginning to the end of surgery)

Study Sites (1)

Loading locations...

Similar Trials